{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T06:05:44Z","timestamp":1745042744941},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,27]]},"DOI":"10.7759\/cureus.29673","type":"journal-article","created":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T05:33:40Z","timestamp":1664343220000},"source":"Crossref","is-referenced-by-count":1,"title":["Thrombolysis in an Acute Ischemic Stroke Patient on Direct Anticoagulant Therapy Outside of the Traditional Time Window: A Case Report"],"prefix":"10.7759","author":[{"given":"Sofie","family":"Moorthamers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Mattar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laeticia","family":"Frezals","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Preseau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Dominique","family":"Gazagnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.16.181636","article-title":"Stroke: a global response is needed","author":"Johnson W","year":"2016","unstructured":"Stroke. a global response is needed. 2016, 94:634-634A. 10.2471\/BLT.16.181636"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000211","article-title":"Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"50","author":"Powers WJ","year":"2019","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, et al.. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2019, 50:e344-418. 10.1161\/STR.0000000000000211","journal-title":"Stroke"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804355","article-title":"MRI-guided thrombolysis for stroke with unknown time of onset","volume":"379","author":"Thomalla G","year":"2018","unstructured":"Thomalla G, Simonsen CZ, Boutitie F, et al.. MRI-guided thrombolysis for stroke with unknown time of onset. N Engl J Med. 2018, 379:611-22. 10.1056\/NEJMoa1804355","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1813046","article-title":"Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke","volume":"380","author":"Ma H","year":"2019","unstructured":"Ma H, Campbell BC, Parsons MW, et al.. Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke. N Engl J Med. 2019, 380:1795-803. 10.1056\/NEJMoa1813046","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-020-02108-5","article-title":"The management of patients with acute ischemic stroke while on direct oral anticoagulants (DOACs): data from an Italian cohort and a proposed algorithm","volume":"50","author":"Rota E","year":"2020","unstructured":"Rota E, Testa L, Di Brigida G, Agosti S, Rovere ME, Risso R, Morelli N. The management of patients with acute ischemic stroke while on direct oral anticoagulants (DOACs): data from an Italian cohort and a proposed algorithm. J Thromb Thrombolysis. 2020, 50:732-8. 10.1007\/s11239-020-02108-5","journal-title":"J Thromb Thrombolysis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.119.026426","article-title":"Safety of intravenous thrombolysis among patients taking direct oral anticoagulants: a systematic review and meta-analysis","volume":"51","author":"Shahjouei S","year":"2020","unstructured":"Shahjouei S, Tsivgoulis G, Goyal N, et al.. Safety of intravenous thrombolysis among patients taking direct oral anticoagulants: a systematic review and meta-analysis. Stroke. 2020, 51:533-41. 10.1161\/STROKEAHA.119.026426","journal-title":"Stroke"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/2396987319863606","article-title":"Consensus statements and recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 11-13 November 2018","volume":"4","author":"Ahmed N","year":"2019","unstructured":"Ahmed N, Audebert H, Turc G, et al.. Consensus statements and recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 11-13 November 2018. Eur Stroke J. 2019, 4:307-17. 10.1177\/2396987319863606","journal-title":"Eur Stroke J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.119.028337","article-title":"Review of perfusion imaging in acute ischemic stroke: from time to tissue","volume":"51","author":"Demeestere J","year":"2020","unstructured":"Demeestere J, Wouters A, Christensen S, Lemmens R, Lansberg MG. Review of perfusion imaging in acute ischemic stroke: from time to tissue. Stroke. 2020, 51:1017-24. 10.1161\/STROKEAHA.119.028337","journal-title":"Stroke"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.114.007117","article-title":"Limited reliability of computed tomographic perfusion acute infarct volume measurements compared with diffusion-weighted imaging in anterior circulation stroke","volume":"46","author":"Schaefer PW","year":"2015","unstructured":"Schaefer PW, Souza L, Kamalian S, et al.. Limited reliability of computed tomographic perfusion acute infarct volume measurements compared with diffusion-weighted imaging in anterior circulation stroke. Stroke. 2015, 46:419-24. 10.1161\/STROKEAHA.114.007117","journal-title":"Stroke"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-032780","article-title":"Optimising acute stroke care organisation: a simulation study to assess the potential to increase intravenous thrombolysis rates and patient gains","volume":"10","author":"Lahr MM","year":"2020","unstructured":"Lahr MM, van der Zee DJ, Luijckx GJ, Buskens E. Optimising acute stroke care organisation: a simulation study to assess the potential to increase intravenous thrombolysis rates and patient gains. BMJ Open. 2020, 10:e032780. 10.1136\/bmjopen-2019-032780","journal-title":"BMJ Open"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0b013e318296f0a9","article-title":"Contraindications to intravenous rtPA for acute stroke: a critical reappraisal","volume":"3","author":"Fugate JE","year":"2013","unstructured":"Fugate JE, Rabinstein AA. Contraindications to intravenous rtPA for acute stroke: a critical reappraisal. Neurol Clin Pract. 2013, 3:177-85. 10.1212\/CPJ.0b013e318296f0a9","journal-title":"Neurol Clin Pract"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000086","article-title":"Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"47","author":"Demaerschalk BM","year":"2016","unstructured":"Demaerschalk BM, Kleindorfer DO, Adeoye OM, et al.. Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2016, 47:581-641. 10.1161\/STR.0000000000000086","journal-title":"Stroke"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.023940","article-title":"Use of intravenous recombinant tissue plasminogen activator in patients with acute ischemic stroke who take non-vitamin K antagonist oral anticoagulants before stroke","volume":"135","author":"Xian Y","year":"2017","unstructured":"Xian Y, Federspiel JJ, Hernandez AF, et al.. Use of intravenous recombinant tissue plasminogen activator in patients with acute ischemic stroke who take non-vitamin K antagonist oral anticoagulants before stroke. Circulation. 2017, 135:1024-35. 10.1161\/CIRCULATIONAHA.116.023940","journal-title":"Circulation"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13582","article-title":"Intravenous thrombolysis for acute ischaemic stroke in patients on direct oral anticoagulants","volume":"25","author":"Touz\u00e9 E","year":"2018","unstructured":"Touz\u00e9 E, Gruel Y, Gouin-Thibault I, De Maistre E, Susen S, Sie P, Derex L. Intravenous thrombolysis for acute ischaemic stroke in patients on direct oral anticoagulants. Eur J Neurol. 2018, 25:747-e52. 10.1111\/ene.13582","journal-title":"Eur J Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1159\/000502335","article-title":"Direct oral anticoagulant plasma levels for the management of acute ischemic stroke","volume":"48","author":"Marsch A","year":"2019","unstructured":"Marsch A, Macha K, Siedler G, et al.. Direct oral anticoagulant plasma levels for the management of acute ischemic stroke. Cerebrovasc Dis. 2019, 48:17-25. 10.1159\/000502335","journal-title":"Cerebrovasc Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1884","article-title":"Laboratory and clinical monitoring of direct acting oral anticoagulants: what clinicians need to know","volume":"37","author":"Conway SE","year":"2017","unstructured":"Conway SE, Hwang AY, Ponte CD, Gums JG. Laboratory and clinical monitoring of direct acting oral anticoagulants: what clinicians need to know. Pharmacotherapy. 2017, 37:236-48. 10.1002\/phar.1884","journal-title":"Pharmacotherapy"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13912","article-title":"Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians","volume":"16","author":"Douxfils J","year":"2018","unstructured":"Douxfils J, Ageno W, Samama CM, et al.. Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians. J Thromb Haemost. 2018, 16:209-19. 10.1111\/jth.13912","journal-title":"J Thromb Haemost"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-013-0560-7","article-title":"Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban","volume":"102","author":"Steiner T","year":"2013","unstructured":"Steiner T, B\u00f6hm M, Dichgans M, et al.. Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban. Clin Res Cardiol. 2013, 102:399-412. 10.1007\/s00392-013-0560-7","journal-title":"Clin Res Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.5853\/jos.2017.00395","article-title":"Intravenous thrombolysis in patients with stroke taking rivaroxaban using drug specific plasma levels: experience with a standard operation procedure in clinical practice","volume":"19","author":"Seiffge DJ","year":"2017","unstructured":"Seiffge DJ, Traenka C, Polymeris AA, et al.. Intravenous thrombolysis in patients with stroke taking rivaroxaban using drug specific plasma levels: experience with a standard operation procedure in clinical practice. J Stroke. 2017, 19:347-55. 10.5853\/jos.2017.00395","journal-title":"J Stroke"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy136","article-title":"The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"39","author":"Steffel J","year":"2018","unstructured":"Steffel J, Verhamme P, Potpara TS, et al.. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J. 2018, 39:1330-93. 10.1093\/eurheartj\/ehy136","journal-title":"Eur Heart J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/113216-thrombolysis-in-an-acute-ischemic-stroke-patient-on-direct-anticoagulant-therapy-outside-of-the-traditional-time-window-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:48:56Z","timestamp":1707508136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/113216-thrombolysis-in-an-acute-ischemic-stroke-patient-on-direct-anticoagulant-therapy-outside-of-the-traditional-time-window-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,27]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.29673","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,27]]}}}